Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data

NCT05264168 · clinicaltrials.gov ↗

COMPLETED

Status

41875

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Pulmonary Embolism
DVT

Interventions

DRUG: Rivaroxaban
DRUG: Apixaban

Sponsor

Brigham and Women's Hospital